Orient Europharma Co

Orient Europharma Co FCF per Share

The Free Cash Flow per Share of Orient Europharma Co (4120.TWO) as of Oct 17, 2026 is -5.54 TWD. In the previous year, Free Cash Flow per Share was -2.55 TWD — a change of 117.28% (lower).

FCF per Share

-5.54TWD

YoY

117.28%

Last updated:

Free Cash Flow per Share of Orient Europharma Co is 2025 -5.54 TWD. Free Cash Flow per Share of Orient Europharma Co was 2024 -2.55 TWD. It decreases by 117.28% lower compared to the previous year.

The Orient Europharma Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
0.34 TWD
Jan 1, 2019
1.18 TWD
Jan 1, 2020
4.33 TWD
Jan 1, 2021
-17.12 TWD
Jan 1, 2022
-9.89 TWD
Jan 1, 2023
-0.42 TWD
Jan 1, 2024
-2.55 TWD
Jan 1, 2025
-5.54 TWD
The Orient Europharma Co FCF per Share history
YEARFCF per ShareYoY
-5.54TWD+117.28%
-2.55TWD+514.30%
-0.42TWD-95.80%
-9.89TWD-42.23%
-17.12TWD-495.24%
4.33TWD+266.99%
1.18TWD+244.70%
0.34TWD-87.27%
2.69TWD-306.24%
-1.30TWD-127.40%
4.76TWD+164.11%
1.80TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Orient Europharma Co Stock analysis

What does Orient Europharma Co do? Orient Europharma Co Ltd, based in Taipei City, Taiwan, operates in the Health Care sector, specifically within Pharmaceuticals. The company manufactures and trades western medicine, health food, and cosmetics, with a focus on nutritious healthcare products, medical cosmetic products, and western drugs. Its product segments include infant milk powders, functional healthcare items, dermatological preparations, medical hair care, organic skincare, and pharmaceuticals for conditions such as cardiovascular diseases, cancer, and diabetes. Listed on 28 November 2002. Orient Europharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orient Europharma Co stock

Free Cash Flow per Share of Orient Europharma Co is -5.54 TWD in 2025.

Free Cash Flow per Share of Orient Europharma Co changed from -2.55 TWD to -5.54 TWD, representing a 117.28% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Orient Europharma Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Orient Europharma Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Orient Europharma Co